MCF Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.5K Buy
380
+160
+73% +$14.7K ﹤0.01% 692
2025
Q4
$19.8K Buy
+220
New +$20.9K ﹤0.01% 695
2024
Q4
Sell
-3
Closed -$325 1052
2024
Q3
$325 Hold
3
﹤0.01% 955
2024
Q2
$327 Hold
3
﹤0.01% 970
2024
Q1
$397 Buy
+3
New +$375 ﹤0.01% 925
2020
Q3
Sell
-6
Closed -$1K 515
2020
Q2
$1K Hold
6
﹤0.01% 466
2020
Q1
$1K Hold
6
﹤0.01% 450
2019
Q4
$1K Hold
6
﹤0.01% 439
2019
Q3
$1K Hold
6
﹤0.01% 440
2019
Q2
$1K Hold
6
﹤0.01% 432
2019
Q1
$1K Hold
6
﹤0.01% 446
2018
Q4
$1K Hold
6
﹤0.01% 469
2018
Q3
$1K Hold
6
﹤0.01% 461
2018
Q2
$1K Hold
6
﹤0.01% 430
2018
Q1
$1K Hold
6
﹤0.01% 457
2017
Q4
$1K Hold
6
﹤0.01% 469
2017
Q3
$1K Hold
6
﹤0.01% 497
2017
Q2
$1K Hold
6
﹤0.01% 489
2017
Q1
$1K Buy
+6
New +$680 ﹤0.01% 442
2016
Q4
Sell
-39
Closed -$5K 477
2016
Q3
$5K Sell
39
-50
-56% -$6.18K ﹤0.01% 374
2016
Q2
$10K Buy
+89
New +$10.1K ﹤0.01% 350

Other funds holding ZBH

MCF Advisors's ZBH Position: Q1 2026 in Review

MCF Advisors increased its Zimmer Biomet (ZBH) stake by 73% in Q1 2026, buying an estimated $14.7K and bringing the position to 380 shares worth $34.5K. The position accounts for ﹤0.01% of the portfolio, ranked #692.

MCF Advisors first reported a position in ZBH in Q2 2016 and has held it in 21 quarters since. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • MCF Advisors held 380 shares of Zimmer Biomet worth $34.5K as of Q1 2026.
  • MCF Advisors bought 160 Zimmer Biomet shares in Q1 2026, an estimated $14.7K.
  • Zimmer Biomet made up ﹤0.01% of MCF Advisors's portfolio in Q1 2026, its #692 holding.
  • MCF Advisors first reported a position in Zimmer Biomet in Q2 2016 and has held it in 21 quarters since.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on MCF Advisors's 13F filing for Q1 2026, filed 11 May 2026.